早期代谢和免疫生物标志物作为COVID-19的预后指标
Zigui Chen1, Erik Fung2,3,4, Chun-Kwok Wong5
1Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR 999077, China.
Metabolites
|July 26, 2024
概括
这项研究确定了用于预测2019年新冠肺炎疾病 (COVID-19) 严重性的关键代谢和免疫生物标志物. 这些生物标志物,包括特定的代谢物和细胞因子,显示出对患者结果分层的强大潜力.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 2019年新冠肺炎疾病 (COVID-19) 构成了全球重大健康挑战.
- 确定可靠的预后生物标志物对于管理疾病严重程度和患者结果至关重要.
- 以前的研究已经探索了各种标记物,但对代谢和免疫相互作用的全面理解仍在发展中.
研究的目的:
- 为了确定2019年新冠肺炎疾病 (COVID-19) 严重程度的预后代谢和免疫生物标志物.
- 调查疾病严重程度与特定代谢物和细胞因子之间的关联.
- 评估这些生物标志物的预测价值和相互关系,以评估患者分层.
主要方法:
- 这是一项前性研究,涉及香港327名COVID-19患者.
- 与疾病严重程度相关的代谢概况和细胞因子/化学因子水平的分析.
- 统计分析包括相关性评估和接收器运行特征 (ROC) 曲线分析以确定预测值 (曲线下的面积 - AUC).
主要成果:
- 疾病的严重程度显著影响了代谢组,在严重病例中,大多数相关代谢物下调调节.
- 十种细胞因子/化学因子与严重程度有很强的关联,所有都显示上调.
- 14种代谢物和5种细胞因子/化学因子显示出高预测值 (AUC>0.8),特定代谢物显示出对严重疾病的高度敏感性或特异性.
- 在多对代谢和免疫生物标志物之间观察到显著的相关性.
结论:
- 代谢和免疫生物标志物密切相互作用,对COVID-19具有显著的预后潜力.
- 这些生物标志物可以实现有效的基于结果的患者分层.
- 这些发现有助于更深入地了解COVID-19病原和生物标志物发现.
关键词:
在这里,我们可以看到COVID COVID COVID.这就是SARS-CoV-2病毒.生物标志物生物标志物这是一种化学物质,chemokine.冠状病毒冠状病毒的新冠病毒.细胞因子细胞因子代谢组代谢组的代谢严重程度的严重程度.更多相关视频
11:02Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
508
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
15.6K
相关概念视频
01:33Proteomics
7.3K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.3K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
69
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
128
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
128